E S Kilpatrick

Summary

Affiliation: Hull Royal Infirmary
Country: UK

Publications

  1. ncbi request reprint HbA1c or glucose for diabetes diagnosis?
    Eric S Kilpatrick
    Ann Clin Biochem 42:165-6. 2005
  2. ncbi request reprint Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, United Kingdom
    Clin Chem 53:897-901. 2007
  3. ncbi request reprint Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabetologia 50:2553-61. 2007
  4. doi request reprint Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabet Med 30:616-9. 2013
  5. doi request reprint Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Edinburgh, UK
    Diabet Med 29:1195-8. 2012
  6. doi request reprint The rise and fall of HbA(1c) as a risk marker for diabetes complications
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull, HU3 2JZ, UK
    Diabetologia 55:2089-91. 2012
  7. pmc A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabetes Care 31:2198-202. 2008
  8. ncbi request reprint Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK
    Diabetologia 51:365-71. 2008
  9. pmc Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabetes Care 32:1901-3. 2009
  10. ncbi request reprint Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Curr Med Res Opin 24:2651-61. 2008

Collaborators

Detail Information

Publications60

  1. ncbi request reprint HbA1c or glucose for diabetes diagnosis?
    Eric S Kilpatrick
    Ann Clin Biochem 42:165-6. 2005
  2. ncbi request reprint Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, United Kingdom
    Clin Chem 53:897-901. 2007
    ..We examined the relationship in different treatment groups of patients with type 1 diabetes participating in the Diabetes Control and Complications Trial (DCCT)...
  3. ncbi request reprint Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabetologia 50:2553-61. 2007
    ..This study re-analysed DCCT data to establish whether mean blood glucose (MBG) and/or glucose variability add to the predictive value of HbA(1c) for hypoglycaemia risk in type 1 diabetes...
  4. doi request reprint Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabet Med 30:616-9. 2013
    ..This study has assessed the impact of this regulation if applied to patients who participated in the Diabetes Control and Complications Trial...
  5. doi request reprint Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Edinburgh, UK
    Diabet Med 29:1195-8. 2012
    ....
  6. doi request reprint The rise and fall of HbA(1c) as a risk marker for diabetes complications
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull, HU3 2JZ, UK
    Diabetologia 55:2089-91. 2012
    ....
  7. pmc A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabetes Care 31:2198-202. 2008
    ..In this study, we analyzed data from the Diabetes Control and Complications Trial (DCCT) to assess the effect of A1C variability on the risk of retinopathy and nephropathy in patients with type 1 diabetes...
  8. ncbi request reprint Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK
    Diabetologia 51:365-71. 2008
    ....
  9. pmc Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabetes Care 32:1901-3. 2009
    ....
  10. ncbi request reprint Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Curr Med Res Opin 24:2651-61. 2008
    ..Good glycaemic control is crucial in reducing the risk of diabetes-related complications. Despite the availability of evidence-based treatment guidelines, glycaemic control appears to remain suboptimal in most countries...
  11. ncbi request reprint Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK
    J Clin Pathol 61:977-82. 2008
    ....
  12. doi request reprint The Diabetes Control and Complications Trial: the gift that keeps giving
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary and Hull York Medical School, Hull, UK
    Nat Rev Endocrinol 5:537-45. 2009
    ..In conclusion, the DCCT continues to provide new insights into type 1 diabetes mellitus, which are of benefit to patients over a quarter of a century after the trial was started...
  13. pmc Arguments for and against the role of glucose variability in the development of diabetes complications
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, United Kingdom
    J Diabetes Sci Technol 3:649-55. 2009
    ..This article reviews the evidence that exists to both support and refute the claim that increased glucose variability should be regarded as an independent risk factor for the development of diabetic vascular disease...
  14. doi request reprint For debate. Glucose variability and diabetes complication risk: we need to know the answer
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, University of Hull, Hull HU3 2JZ, UK
    Diabet Med 27:868-71. 2010
    ..While this article focuses on the data which do not support a role for glucose variability in the development of complications, it also highlights the need for further studies to be performed which will definitively resolve the matter...
  15. doi request reprint A national survey of interpretative reporting in the UK
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Ann Clin Biochem 48:317-20. 2011
    ..Little is known about the extent of this activity in individual laboratories throughout the UK and so this national survey aimed to establish the prevalence...
  16. doi request reprint A national audit of estimated glomerular filtration rate and proteinuria reporting in the UK
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK
    Ann Clin Biochem 48:558-61. 2011
    ..Guidance has also changed since its original introduction. This national audit aimed to establish how eGFR is reported by laboratories within the UK...
  17. ncbi request reprint Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK
    Diabetes Care 30:707-12. 2007
    ..This study has examined whether these also were predictors of micro- and macrovascular complications in type 1 diabetic patients participating in the Diabetes Control and Complications Trial (DCCT)...
  18. ncbi request reprint The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ
    Diabetes Care 29:1486-90. 2006
    ..This study has analyzed data from the Diabetes Control and Complications Trial (DCCT) to assess the effect of glucose variability on the risk of retinopathy and nephropathy in patients with type 1 diabetes...
  19. pmc The role of blood pressure variability in the development of nephropathy in type 1 diabetes
    Eric S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabetes Care 33:2442-7. 2010
    ..This study has investigated whether each may also influence the development of microvascular complications in type 1 diabetes by examining data from the Diabetes Control and Complications Trial (DCCT)...
  20. doi request reprint Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls
    L W Cho
    Department of Endocrinology and Diabetes, University of Hull, Hull, UK
    Horm Metab Res 43:141-5. 2011
    ..Since anovulatory PCOS therefore mimics the IR features of type 2 diabetes more closely, anovulation may be particularly associated with a higher cardiovascular risk compared to PCOS patients who ovulate...
  21. ncbi request reprint Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome
    V Jayagopal
    Department of Medicine, University of Hull, Michael White Centre for Diabetes and Endocrinology, Hull Royal Infirmary, Hull HU3 2RW, UK
    J Clin Endocrinol Metab 90:729-33. 2005
    ..The reduction in total testosterone was similar to that seen after treatment with metformin. Therefore, orlistat may prove to be a useful adjunct in the treatment of PCOS...
  22. doi request reprint The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study
    T Sathyapalan
    Department of Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, University of Hull, Hull, UK
    Diabetes Obes Metab 15:767-9. 2013
    ..Thus, compared with simvastatin, atorvastatin shows apparently beneficial pleiotropic effects with respect to 25OHD concentrations as well as markers of oxidative stress and inflammation in patients with T2DM. ..
  23. ncbi request reprint Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight change
    S Gonzalez
    Department of Medicine, University of Hull, Hull, UK
    Diabet Med 22:344-5. 2005
    ..5% (from 9.3 to 8.8%). Six months after orlistat was stopped her HbA(1c) rose to 10.5% and weight increased to 81.8 kg (BMI 41.8). Despite the orlistat treatment broaching NICE guidelines should it have been continued?..
  24. doi request reprint Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?
    T Sathyapalan
    Department of Diabetes, Endocrinology and Metabolism, Hull York Medical School, Hull, UK
    Diabetes Obes Metab 12:540-4. 2010
    ..This study compared the biological variability of direct LDL in patients with type 2 diabetes (T2DM) on equivalent doses of the short half-life statin, simvastatin or the longer half-life statin, atorvastatin...
  25. doi request reprint Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
    L W Cho
    Department of Medicine, University of Hull, Hull, UK
    Clin Endocrinol (Oxf) 70:233-7. 2009
    ..Whilst treatment will reduce the mean IR, it is not known if the IR variability is also reduced...
  26. ncbi request reprint Determinants of raised C-reactive protein concentration in type 1 diabetes
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    QJM 93:231-6. 2000
    ..The reasons for this, and whether intervention would prove useful, require further investigation...
  27. ncbi request reprint Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia
    L W Cho
    Department of Medicine, University of Hull, UK
    Clin Endocrinol (Oxf) 68:390-4. 2008
    ..The aim of this study was to compare the biological variability of total testosterone with that of the biological variability of both the FAI and BioT, to determine the least variable measurement for clinical practice...
  28. doi request reprint The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes
    Li Wei Cho
    Department of Medicine University of Hull, Hull Royal Infirmary, Hull, UK
    Ann Clin Biochem 46:218-21. 2009
    ..To test this hypothesis we compared the mean and biological variation in IR in PCOS to that of T2DM and to age- and weight-matched controls...
  29. doi request reprint Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity
    H Kahal
    Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK
    Clin Endocrinol (Oxf) 79:252-8. 2013
    ..Previous studies investigating cardiovascular (CV) risk in obese women with polycystic ovary syndrome (PCOS) have been potentially confounded by not adequately accounting for body weight...
  30. doi request reprint The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes
    J Ng
    Diabetes Centre, Michael White Centre, Hull Royal Infirmary Academic, University of Hull, Hull, UK
    Diabet Med 28:519-24. 2011
    ..To examine the impact of extensive flooding in a UK city in 2007 on the glycaemic control of patients with diabetes mellitus...
  31. ncbi request reprint Establishing pragmatic estimated GFR thresholds to guide metformin prescribing
    J S Shaw
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull HU3 2JZ, UK
    Diabet Med 24:1160-3. 2007
    ..This study aimed to establish pragmatic eGFR limits for use in patients being considered for metformin treatment...
  32. pmc Does adjustment of GFR to extracellular fluid volume improve the clinical utility of cystatin C?
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK
    Arch Dis Child 82:499-502. 2000
    ..It has also been suggested that GFR itself should be adjusted to the extracellular fluid volume (ECV) of a child rather than the body surface area (BSA)...
  33. doi request reprint Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
    K M Goode
    Department of Cardiology, Division of Cardiovascular and Respiratory Studies, Postgraduate Medical Institute, Castle Hill Hospital, Kingston upon Hull, UK
    Heart 95:917-23. 2009
    ..However, its relationship to survival in patients with suspected heart failure has not been studied...
  34. doi request reprint Mortality at low and high estimated glomerular filtration rate values: a 'U' shaped curve
    Heidi J Cox
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Nephron Clin Pract 110:c67-72. 2008
    ..While a low estimated glomerular filtration rate (eGFR) confers an increased risk of dying, the mortality associated with high eGFR values has not been ascertained...
  35. doi request reprint Is there still a role for measuring serum urea in an age of eGFR? Evidence of its use when assessing patient hydration
    John Shepherd
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Nephron Clin Pract 113:c203-6. 2009
    ..The aim of this study was to compare serum urea and eGFR with urine specific gravity (USG) to establish how each compares with this surrogate marker of hydration status...
  36. ncbi request reprint Use of haemolysis index to estimate potassium concentration in in-vitro haemolysed serum samples
    John Shepherd
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Clin Chem Lab Med 44:877-9. 2006
    ..However, estimation of the degree of potassium adjustment has not been validated with patient-derived data. This study aimed to ascertain the relationship between haemolysis and potassium increment using patient samples...
  37. pmc The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease
    Jen M Ng
    Department of Diabetes and Endocrinology, Hull York Medical School, East Yorkshire, UK
    Diabetes Care 33:2310-3. 2010
    ..To examine the effect of intravenous iron and erythropoietin-stimulating agents (ESAs) on glycemic control and A1C of patients with diabetes and chronic kidney disease (CKD)...
  38. doi request reprint Biological variation of cardiovascular risk factors in patients with diabetes
    A J Dawson
    Department of Diabetes and Endocrinology, University of Hull, Hull, UK
    Diabet Med 30:1172-80. 2013
    ..The role of biological variation in the diagnosis of diabetes (glucose and HbA1c) is then examined. Finally, the influence that common treatments in diabetes have in modifying biological variation is described...
  39. ncbi request reprint Short-term glucose variability in healthy volunteers is not associated with raised oxidative stress markers
    A Wakil
    Michael White Diabetes Centre, Hull Royal Infirmary, Hull, UK
    Diabetes Obes Metab 14:1047-9. 2012
    ..083. In conclusion, we did not see a significant increase in the urinary isoprostanes when glycaemic variability was induced under controlled conditions in healthy individuals...
  40. pmc Use of computer terminals on wards to access emergency test results: a retrospective audit
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull HU3 2JZ
    BMJ 322:1101-3. 2001
    ..To assess delay in clinicians obtaining emergency biochemistry test results when the telephoning of results by laboratory staff is supplanted by installation of computer ward terminals...
  41. ncbi request reprint High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients
    D D Mellor
    HONEI, University of Hull, Hull, UK
    Diabet Med 27:1318-21. 2010
    ..To examine the effects of chocolate on lipid profiles, weight and glycaemic control in individuals with Type 2 diabetes...
  42. ncbi request reprint Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, UK
    Diabet Med 16:496-9. 1999
    ..This study has sought to establish whether plasma 1,5AG can be influenced by not only hyperglycaemia, but by variations in renal threshold for glucose...
  43. doi request reprint A comparison of methods for the measurement of 8-isoPGF(2α): a marker of oxidative stress
    K A Smith
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU32JZ, UK
    Ann Clin Biochem 48:147-54. 2011
    ..However, discrepancies between the specificity of these methods means correlation is poor...
  44. doi request reprint Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting
    T Sathyapalan
    Department of Diabetes and Endocrinology, University of Hull and Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Diabet Med 25:909-15. 2008
    ..To determine the biological variability of lipids in patients with Type 2 diabetes (T2DM) who are on statin treatment and then to assess any implications for current lipid targets...
  45. ncbi request reprint Stability of creatinine with delayed separation of whole blood and implications for eGFR
    J Shepherd
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK
    Ann Clin Biochem 44:384-7. 2007
    ....
  46. ncbi request reprint The biological variation of insulin resistance in polycystic ovarian syndrome
    V Jayagopal
    Department of Medicine, University of Hull, United Kingdom
    J Clin Endocrinol Metab 87:1560-2. 2002
    ..IR, measured using the homeostasis model assessment model, is significantly greater and more variable for overweight patients with PCOS. Therefore, this inherent variability needs to be accounted for in studies of IR in PCOS...
  47. ncbi request reprint Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone
    M H Warner
    Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK
    Ann Clin Biochem 43:196-9. 2006
    ..We have evaluated the potential for dehydroepiandrosterone sulphate (DHEA-S) to cross-react in the Abbott Architect testosterone assay...
  48. ncbi request reprint Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes
    Vijay Jayagopal
    Department of Medicine, University of Hull, Hull, U K
    Diabetes Care 25:1709-14. 2002
    ..The aim of this study was to determine whether a dietary supplement with soy protein and isoflavones affected insulin resistance, glycemic control, and cardiovascular risk markers in postmenopausal women with type 2 diabetes...
  49. doi request reprint Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment
    J Konya
    Department of Diabetes and Endocrinology, University of Hull, Hull, UK
    Diabet Med 30:1250-4. 2013
    ..The study aimed to evaluate the utility of the complementary glycaemic markers glycated albumin, fructosamine and 1,5 anhydroglucitol in this group of patients...
  50. ncbi request reprint Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine
    E S Kilpatrick
    Department of Clinical Biochemistry, Hull Royal Infirmary, Hull HU3 2JZ, UK
    Ann Clin Biochem 41:227-9. 2004
    ....
  51. ncbi request reprint Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism
    Vijay Jayagopal
    Department of Medicine, University of Hull, United Kingdom
    Clin Chem 49:680-1. 2003
  52. doi request reprint The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study
    Thozhukat Sathyapalan
    Department of Diabetes and Endocrinology, University of Hull, Hull HU6 7RX, United Kingdom
    J Clin Endocrinol Metab 94:103-8. 2009
    ..Statins can also reduce testosterone in vitro by inhibiting ovarian theca-interstitial cell proliferation and steroidogenesis and reducing inflammation in vivo...
  53. ncbi request reprint Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes
    Vijay Jayagopal
    Department of Medicine, University of Hull, Hull, U K
    Diabetes Care 25:2022-5. 2002
    ..Insulin resistance is a major determinant of this increased risk and is a potential therapeutic target. This study was undertaken to establish the natural biological variation of insulin resistance in individuals with type 2 diabetes...
  54. doi request reprint A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study
    Thozhukat Sathyapalan
    Department of Diabetes and Endocrinology, University of Hull, Hull, UK
    Clin Endocrinol (Oxf) 69:931-5. 2008
    ..Rimonabant has been found to reduce weight and improve the metabolic profile in patients with obesity, type 2 diabetes and metabolic syndrome...
  55. doi request reprint Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS)
    Thozhukat Sathyapalan
    Department of Diabetes and Endocrinology, University of Hull, Hull, UK
    Clin Endocrinol (Oxf) 70:124-8. 2009
    ..This study was undertaken to determine if subsequent metformin treatment after rimonabant would maintain the improvement in weight, insulin resistance and hyperandrogenaemia in PCOS...
  56. ncbi request reprint The biological variation of sex hormone-binding globulin in type 2 diabetes: implications for sex hormone-binding globulin as a surrogate marker of insulin resistance
    Vijay Jayagopal
    Diabetes Care 27:278-80. 2004
  57. ncbi request reprint Letter to the editor in response to the article 'the impact of apathy on glycemic control in diabetes: a cross-sectional study'
    Eric S Kilpatrick
    Diabetes Res Clin Pract 79:e19-20. 2008
  58. ncbi request reprint The biological variation of C-reactive protein in polycystic ovarian syndrome
    Li Wei Cho
    Clin Chem 51:1905-7. 2005
  59. pmc Was it a heart attack? Troponin measurement is not straightforward
    Eric S Kilpatrick
    BMJ 324:1216. 2002